Antihypertensive drugs and risk of COVID-19?

Christopher J. Tignanelli; Nicholas E. Ingraham; Matthew A. Sparks; Ronald Reilkoff; Tamara Bezdicek; Bradley Benson; Timothy Schacker; Jeffrey G. Chipman; Michael A. Puskarich

doi:10.1016/S2213-2600(20)30153-3

Antihypertensive drugs and risk of COVID-19?

Christopher J. Tignanelli, Nicholas E. Ingraham, Matthew A. Sparks, Ronald Reilkoff, Tamara Bezdicek, Bradley Benson, Timothy Schacker, Jeffrey G. Chipman, Michael A. Puskarich

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Original language	English (US)
Pages (from-to)	e30-e31
Journal	The Lancet Respiratory Medicine
Volume	8
Issue number	5
DOIs	https://doi.org/10.1016/S2213-2600(20)30153-3
State	Published - May 2020

PubMed: MeSH publication types

Letter
Research Support, N.I.H., Extramural
Comment

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/S2213-2600(20)30153-3

Find It

Find It at U of M Libraries

Cite this

@article{d53c88d9a28e46ef9402c06cd6ca69c7,

title = "Antihypertensive drugs and risk of COVID-19?",

author = "Tignanelli, {Christopher J.} and Ingraham, {Nicholas E.} and Sparks, {Matthew A.} and Ronald Reilkoff and Tamara Bezdicek and Bradley Benson and Timothy Schacker and Chipman, {Jeffrey G.} and Puskarich, {Michael A.}",

year = "2020",

month = may,

doi = "10.1016/S2213-2600(20)30153-3",

language = "English (US)",

volume = "8",

pages = "e30--e31",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",